These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17545691)

  • 1. Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer.
    Kangelaris KN; Gruber SB
    JAMA; 2007 Jun; 297(21):2410-1. PubMed ID: 17545691
    [No Abstract]   [Full Text] [Related]  

  • 2. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.
    Suriano G; Yew S; Ferreira P; Senz J; Kaurah P; Ford JM; Longacre TA; Norton JA; Chun N; Young S; Oliveira MJ; Macgillivray B; Rao A; Sears D; Jackson CE; Boyd J; Yee C; Deters C; Pai GS; Hammond LS; McGivern BJ; Medgyesy D; Sartz D; Arun B; Oelschlager BK; Upton MP; Neufeld-Kaiser W; Silva OE; Donenberg TR; Kooby DA; Sharma S; Jonsson BA; Gronberg H; Gallinger S; Seruca R; Lynch H; Huntsman DG
    Clin Cancer Res; 2005 Aug; 11(15):5401-9. PubMed ID: 16061854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mutations identified for hereditary diffuse gastric cancer.
    Peek R; Reddy KR
    Gastroenterology; 2007 Aug; 133(2):379-80. PubMed ID: 17681152
    [No Abstract]   [Full Text] [Related]  

  • 6. CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer.
    Lajus TB; Sales RM
    Gene; 2015 Sep; 568(2):215-9. PubMed ID: 25981591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Associations of E-cadherin gene (CDH1) and hereditary gastric cancer in China].
    Song W; He YL; Zhang CH; Cai SR; Zhou XF; Peng JJ; Wang Z; Yang DJ; Zhan WH
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1204-8. PubMed ID: 19781162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preventive resection of hereditary diffuse gastric cancer].
    Hoogerbrugge N; Ligtenberg MJ; Nagengast FM; Bonenkamp JJ; van Krieken JH
    Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2417-20. PubMed ID: 17131699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a center of excellence for hereditary diffuse gastric cancer syndrome.
    Drake J; Schreiber KC; Lopez R; Fasaye GA; Connolly M; Quezado M; Heller T; Hernandez JM; Davis JL
    J Surg Oncol; 2019 May; 119(6):673-674. PubMed ID: 30618047
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation.
    Benusiglio PR; Colas C; Rouleau E; Uhrhammer N; Romero P; Remenieras A; Moretta J; Wang Q; De Pauw A; Buecher B; Stoppa-Lyonnet D; Mouret-Fourme E; Noguès C; Di Maria M; Tlemsani C; Warcoin M; Grandjouan S; Malka D; Caron O; Blayau M
    J Med Genet; 2015 Aug; 52(8):563-5. PubMed ID: 26025002
    [No Abstract]   [Full Text] [Related]  

  • 11. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer.
    Shah MA; Salo-Mullen E; Stadler Z; Ruggeri JM; Mirander M; Pristyazhnyuk Y; Zhang L
    Clin Genet; 2012 Sep; 82(3):283-7. PubMed ID: 21696387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
    Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
    J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial gastric cancer and germline mutations of E-cadherin.
    Corso G; Marrelli D; Roviello F
    Ann Ital Chir; 2012; 83(3):177-82. PubMed ID: 22595728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
    Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cate's Story: Hereditary Diffuse Gastric Cancer.
    Rogers M
    Clin J Oncol Nurs; 2016 Aug; 20(4):443-5. PubMed ID: 27441520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of E-cadherin germ-line alterations with prostate cancer.
    Ikonen T; Matikainen M; Mononen N; Hyytinen ER; Helin HJ; Tommola S; Tammela TL; Pukkala E; Schleutker J; Kallioniemi OP; Koivisto PA
    Clin Cancer Res; 2001 Nov; 7(11):3465-71. PubMed ID: 11705864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
    More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P
    Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.